Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Enterotoxigenic Escherichia coli (ETEC) heat-stable toxin N12S mutant is a genetically modified version of the native ETEC heat-stable enterotoxin (STa), in which the asparagine at position 12 is replaced by serine (N12S). This mutation is designed to reduce toxicity while retaining immunogenicity, making it suitable for use in vaccine development against ETEC-induced diarrhea. The mutant is designed to act as a toxoid to induce neutralizing antibodies capable of preventing the wild-type toxin from binding and activating guanylyl cyclase C.
The N12S mutation reduces the enterotoxic activity of STa but preserves its antigenic properties, allowing it to induce neutralizing antibodies without causing disease symptoms. Vaccine candidates work by eliciting antibodies that neutralize the wild-type STa toxin, preventing it from activating guanylyl cyclase C receptors and causing fluid secretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterotoxigenic Escherichia coli Heat-Stable Toxin N12S Mutant.